Page last updated: 2024-08-17

diethylnitrosamine and pd 0325901

diethylnitrosamine has been researched along with pd 0325901 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hennig, M; Klein, PJ; Schmidt, CM; Sebolt-Leopold, J; Wentz, SC; Wu, H; Yip-Schneider, MT	1

Other Studies

1 other study(ies) available for diethylnitrosamine and pd 0325901

Article	Year
Targeting MEK is effective chemoprevention of hepatocellular carcinoma in TGF-alpha-transgenic mice. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2008, Volume: 12, Issue:1 Topics: Alkylating Agents; Animals; Apoptosis; Benzamides; Carcinoma, Hepatocellular; Cell Proliferation; Chemoprevention; Diethylnitrosamine; Diphenylamine; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Follow-Up Studies; Hepatocytes; Immunohistochemistry; Ki-67 Antigen; Liver Neoplasms, Experimental; Mice; Mice, Transgenic; Transforming Growth Factor alpha	2008

Article

Year

Targeting MEK is effective chemoprevention of hepatocellular carcinoma in TGF-alpha-transgenic mice.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2008, Volume: 12, Issue:1

Topics: Alkylating Agents; Animals; Apoptosis; Benzamides; Carcinoma, Hepatocellular; Cell Proliferation; Chemoprevention; Diethylnitrosamine; Diphenylamine; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Follow-Up Studies; Hepatocytes; Immunohistochemistry; Ki-67 Antigen; Liver Neoplasms, Experimental; Mice; Mice, Transgenic; Transforming Growth Factor alpha

2008